Arch Therapeutics Inc (ARTH)
1.48
+0.43
(+40.95%)
USD |
OTCM |
May 20, 16:00
Arch Therapeutics Profit Margin (Quarterly): -4.61K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.61K% |
| December 31, 2023 | -5.85K% |
| September 30, 2023 | -6.22K% |
| June 30, 2023 | -13.71K% |
| March 31, 2023 | -5.42K% |
| December 31, 2022 | -28.75K% |
| September 30, 2022 | -120.6K% |
| Date | Value |
|---|---|
| June 30, 2022 | -16.72K% |
| March 31, 2022 | -25.25K% |
| December 31, 2021 | -33.01K% |
| September 30, 2021 | -112.8K% |
| June 30, 2021 | |
| March 31, 2021 | -17.91K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-120.6K%
Minimum
Sep 2022
-4.61K%
Maximum
Mar 2024
-32.57K%
Average
-17.32K%
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.79% |
| Asensus Surgical Inc | -2.00K% |
| Senseonics Holdings Inc | -374.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -497.3% |
| Gross Profit Margin (Quarterly) | 32.36% |
| Operating Margin (Quarterly) | -2.75K% |
| Return on Net Operating Assets | -569.7% |